Safilo Group S.p.A. (SAFLF)
USD 0.98
(0.0%)
USD 0.98
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 459.67 Million EUR | -11.83% |
| 2022 | 521.34 Million EUR | -8.8% |
| 2021 | 571.68 Million EUR | -21.42% |
| 2020 | 727.55 Million EUR | 49.29% |
| 2019 | 487.34 Million EUR | -10.32% |
| 2018 | 543.4 Million EUR | -14.47% |
| 2017 | 635.32 Million EUR | -2.89% |
| 2016 | 654.25 Million EUR | 10.48% |
| 2015 | 592.2 Million EUR | -5.04% |
| 2014 | 623.64 Million EUR | 0.66% |
| 2013 | 619.57 Million EUR | -1.42% |
| 2012 | 628.47 Million EUR | -4.79% |
| 2011 | 660.11 Million EUR | -6.76% |
| 2010 | 707.95 Million EUR | -25.06% |
| 2009 | 944.63 Million EUR | -6.76% |
| 2008 | 1.01 Billion EUR | 8.81% |
| 2007 | 931.05 Million EUR | -3.96% |
| 2006 | 969.45 Million EUR | -4.82% |
| 2005 | 1.01 Billion EUR | -11.72% |
| 2004 | 1.15 Billion EUR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 431.6 Million EUR | 0.0% |
| 2024 Q1 | 431.6 Million EUR | -6.11% |
| 2023 Q4 | 459.67 Million EUR | 0.0% |
| 2023 Q1 | 493.97 Million EUR | -5.25% |
| 2023 Q3 | 459.67 Million EUR | -6.94% |
| 2023 Q2 | 493.97 Million EUR | 0.0% |
| 2023 FY | 459.67 Million EUR | -11.83% |
| 2022 Q3 | 521.34 Million EUR | -8.32% |
| 2022 Q4 | 521.34 Million EUR | 0.0% |
| 2022 FY | 521.34 Million EUR | -8.8% |
| 2022 Q1 | 568.63 Million EUR | -0.53% |
| 2022 Q2 | 568.63 Million EUR | 0.0% |
| 2021 Q2 | 737.96 Million EUR | 0.0% |
| 2021 Q3 | 571.68 Million EUR | -22.53% |
| 2021 Q1 | 737.96 Million EUR | 1.43% |
| 2021 Q4 | 571.68 Million EUR | 0.0% |
| 2021 FY | 571.68 Million EUR | -21.42% |
| 2020 Q1 | 779.31 Million EUR | 59.91% |
| 2020 Q3 | 727.55 Million EUR | -6.64% |
| 2020 Q2 | 779.31 Million EUR | 0.0% |
| 2020 FY | 727.55 Million EUR | 49.29% |
| 2020 Q4 | 727.55 Million EUR | 0.0% |
| 2019 Q1 | 530.47 Million EUR | -2.38% |
| 2019 Q3 | 487.34 Million EUR | -8.13% |
| 2019 Q2 | 530.47 Million EUR | -0.0% |
| 2019 FY | 487.34 Million EUR | -10.32% |
| 2019 Q4 | 487.34 Million EUR | 0.0% |
| 2018 Q3 | 484.23 Million EUR | -26.6% |
| 2018 Q1 | 595.94 Million EUR | -6.2% |
| 2018 FY | 543.4 Million EUR | -14.47% |
| 2018 Q4 | 543.4 Million EUR | 12.22% |
| 2018 Q2 | 659.74 Million EUR | 10.71% |
| 2017 Q2 | 661.23 Million EUR | 0.0% |
| 2017 Q1 | 661.23 Million EUR | 1.07% |
| 2017 FY | 635.32 Million EUR | -2.89% |
| 2017 Q4 | 635.32 Million EUR | 0.0% |
| 2017 Q3 | 635.32 Million EUR | -3.92% |
| 2016 Q1 | 610.18 Million EUR | 3.04% |
| 2016 FY | 654.25 Million EUR | 10.48% |
| 2016 Q4 | 654.25 Million EUR | 0.0% |
| 2016 Q3 | 654.25 Million EUR | 7.22% |
| 2016 Q2 | 610.18 Million EUR | 0.0% |
| 2015 Q3 | 560.56 Million EUR | -7.23% |
| 2015 Q4 | 592.2 Million EUR | 5.64% |
| 2015 Q2 | 604.27 Million EUR | -3.41% |
| 2015 FY | 592.2 Million EUR | -5.04% |
| 2015 Q1 | 625.6 Million EUR | 0.31% |
| 2014 Q3 | 634.09 Million EUR | -2.54% |
| 2014 Q4 | 623.64 Million EUR | -1.65% |
| 2014 Q1 | 633.34 Million EUR | 2.22% |
| 2014 FY | 623.64 Million EUR | 0.66% |
| 2014 Q2 | 650.59 Million EUR | 2.72% |
| 2013 Q4 | 619.57 Million EUR | 7.65% |
| 2013 FY | 619.57 Million EUR | -1.42% |
| 2013 Q3 | 575.54 Million EUR | -4.43% |
| 2013 Q2 | 602.22 Million EUR | -3.95% |
| 2013 Q1 | 626.96 Million EUR | -0.24% |
| 2012 Q2 | 659.25 Million EUR | -1.12% |
| 2012 Q4 | 628.47 Million EUR | 4.61% |
| 2012 FY | 628.47 Million EUR | -4.79% |
| 2012 Q1 | 666.71 Million EUR | 1.0% |
| 2012 Q3 | 600.78 Million EUR | -8.87% |
| 2011 FY | 660.11 Million EUR | -6.76% |
| 2011 Q1 | 693.29 Million EUR | -2.07% |
| 2011 Q2 | 685.89 Million EUR | -1.07% |
| 2011 Q3 | 668.44 Million EUR | -2.54% |
| 2011 Q4 | 660.11 Million EUR | -1.25% |
| 2010 FY | 707.95 Million EUR | -25.06% |
| 2010 Q1 | 724.1 Million EUR | -23.35% |
| 2010 Q2 | 758.53 Million EUR | 4.75% |
| 2010 Q4 | 707.95 Million EUR | 1.64% |
| 2010 Q3 | 696.52 Million EUR | -8.17% |
| 2009 Q4 | 944.63 Million EUR | 0.0% |
| 2009 FY | 944.63 Million EUR | -6.76% |
| 2008 FY | 1.01 Billion EUR | 8.81% |
| 2007 FY | 931.05 Million EUR | -3.96% |
| 2006 FY | 969.45 Million EUR | -4.82% |
| 2005 FY | 1.01 Billion EUR | -11.72% |
| 2004 FY | 1.15 Billion EUR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| American Medical Technologies Inc. | 2.34 Million USD | -19461.979% |
| Ansell Limited | 1.32 Billion USD | 65.435% |
| Ansell Limited | 1.33 Billion USD | 65.5% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 126.33 Million USD | -263.847% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 943.17 Thousand USD | -48637.24% |
| Psykey, Inc. | 2.47 Million USD | -18480.132% |
| ConvaTec Group Plc | 2.01 Billion USD | 77.223% |
| ConvaTec Group Plc | 2.02 Billion USD | 77.255% |
| Encision Inc. | 1.98 Million USD | -23069.527% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | 3.04 Million USD | -15018.539% |
| Innovative MedTech Inc. | 6.13 Million USD | -7392.873% |
| LifePoint, Inc. | 2.45 Million USD | -18630.413% |
| Medite Cancer Diagnostics, Inc. | 10.18 Million USD | -4415.038% |
| Paradigm Medical Industries, Inc. | 3.4 Million USD | -13419.882% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 3.04 Million USD | -15019.315% |
| Reflect Scientific, Inc. | 776.32 Thousand USD | -59111.494% |
| SmileDirectClub, Inc. | 982.26 Million USD | 53.202% |
| Sector 10, Inc. | 9.84 Million USD | -4568.929% |
| Shandong Weigao Group Medical Polymer Company Limited | 1.35 Billion USD | 66.093% |
| SheerVision, Inc. | 1.43 Million USD | -32013.667% |
| United Health Products, Inc. | 1.99 Million USD | -22896.805% |
| Vasamed, Inc. | 1 Million USD | -45625.256% |
| Wearable Health Solutions, Inc. | 3.8 Million USD | -11995.83% |
| Yubo International Biotech Limited | 2.91 Million USD | -15675.154% |